Institut Gustave Roussy
21 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
2
Ending by 2030
Aug 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 7, 2027The maintenance fee for Novel Derivatives of Oxazaphosphorines That Are Pre-Activated, Use and Method of Preparation (US 9,073,957) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.
- 2 fees due Feb 22, 2027
- 1 fee due Aug 11, 2027The maintenance fee for Diagnostic of chronic myelomonocytic leukemia (CMML) by flow cytometry (US 10,557,849) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Oct 16, 2027The maintenance fee for Means for transporting persons with reduced mobility comprising a device with for connecting to aserum holder, associated connecting assembly (US 11,957,868) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,980,280 | Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope Gene In force · Low confidence | In force | Low confidence | |
| US 11,203,788 | TET2 as a Diagnostic and Pronostic Marker in Hematopoietic Neoplasms In force · High confidence | In force | High confidence | |
| US 9,073,957 | Novel Derivatives of Oxazaphosphorines That Are Pre-Activated, Use and Method of Preparation In force · High confidence | In force | High confidence | |
| US 9,428,530 | Novel Derivatives of Oxazaphosphorines That Are Pre-Activated, Use and Method of Preparation In force · Medium confidence | In force | Medium confidence | |
| US 8,895,027 | Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope Gene In force · High confidence | In force | High confidence | |
| US 11,344,586 | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment In force · From the USPTO record | In force | From the USPTO record | |
| US 10,098,901 | Novel Derivatives of Oxazaphosphorines and Therapeutic Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,899,838 | Antibody Which Is Directed Against GALECTIN-9 and Is an Inhibitor of the Suppressor Activity of Regulatory T Lymphocytes In force · High confidence | In force | High confidence | |
| US 12,516,125 | Antibody which is Directed Against Galectin-9 and is an Inhibitor of the Suppressor Activity of Regulatory T Lymphocytes In force · Medium confidence | In force | Medium confidence | |
| US 10,765,710 | Combination of oncolytic virus with immune checkpoint modulators In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 25: 21 patents in force now held by others · 37 lapsed for an unpaid fee · 29 ended at full term · 1 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
15 pending · 25 abandoned · 23 no status recorded